Directory · KR
Pharmaceutical Manufacturing in South Korea
A register of firms and the professionals working at them in the Pharmaceutical Manufacturing sector based in South Korea. Browse the public index, then filter or export on Kipplo.
Companies
216 on file
Jw Pharmaceutical Corporation
JW Pharmaceutical Corp.(formerly Choongwae Pharma) is one of the leading pharmaceutical companies in Korea with core competencies in antibiotics, IV solutions, and anti-cancer treatments. JW is currently exploring targeted therapies in oncology leveraging the collaborative research and development strengths from the JW Drug Discovery Center in Korea and the JW Theriac Corp in the US. This R&D pipeline is driven by our platform technologies that have the potential to eradicate cancer stem cells selectively through a molecularly targeted approach- JW Group consists of JW Holdings, JW Pharmaceutical, JW Medical, JW ShinYak, JW Industrial, JW Life Science, and JW Creagene. JW possesses i) magnificent sales force (900 reps) for the hospital market, ii) strong relationships with managements of hospitals & and hospital pharmacies, excellent rapport with key opinion leaders in endocrinology, gastroenterology, oncology, cardiology, nephrology, urology and the general surgery therapeutic areas. JW's total sales revenue of US $ 0.7 billion was derived from Korea and other several Asian countries in 2012
1001 to 5000 staff
Celltrion Inc
Celltrion is a leading biopharmaceutical company that specializes in research, development and manufacturing of innovative therapeutics. We are committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. We have been at the forefront of biotherapeutic development uncovering new ways of targeting the drivers of disease by creating next-generation biologics and small molecule products. For additional information on our guidelines, please visit: https://bit.ly/4jv2wf2
1001 to 5000 staff
C&r Research, Inc
C&R Research is Korea’s first and leading CRO with over 28 years of experience. We have conducted over 1,800 clinical trials worldwide, proving our expertise and capabilities. Our experienced professionals and global clinical expertise empower us to deliver high-quality, cost-effective services. Subsidiaries in the U.S, Singapore, and Thailand enhance our support for multinational trials. Supported by a strong global network, C&R Research is expanding as a Korea-based global CRO, providing comprehensive clinical trial services that benefit clients worldwide.
501 to 1000 staff
Dong-A Pharmaceutical Co.,ltd
Dong-A Pharmaceutical Co, Ltd. Established in 1932, Dong-A Pharm. has been the leading pharmaceutical company in South Korea with its business focus in developing, manufacturing and distributing innovative products for the healthier life of our society. Headquartered in South Korea, Dong-A Pharm. employs over 2,300 people worldwide. Business portfolio: ETC, OTC + Bacchus (Energy Drink), Diagnostic & Medical Equipment, Bio-technology etc. For more information, please visit our website:
1001 to 5000 staff
Kolon Pharmaceutical, Inc
Kolon Pharmaceutical, Inc. was established in 1958 with a mission to contribute on happiness of mankind and social welfare by enhancing people’s quality of life and providing top medical service thru development of innovative drugs with its respect for life and health. Kolon Pharmaceutical is a subsidiary of Kolon group which is one of the biggest industrial conglomerates of Korea that has core business domains in pharmaceuticals, biotechnology, cutting-edge materials, fashion, construction, environment, trade and IT. Kolon group’s health business unit is composed of three subsidiaries and they are Kolon Pharmaceuticals, Kolon Life Science(biotechnology) and Kolon Wellcare(drug store business). Kolon Pharmaceutical developed many outstanding products like Bicogreen for constipation, cold remedy Comy syrup & tablet, anti-fungal drug Konitra and Tamsulo capsule for prostatism with its own technology and also co-developed Brexin tablet(β-Cyclodextrin Prioxicam), Remicut SR capsule(Emedastine difumarate) and Pransus syrup(Pranoprofen) with outstanding pharmaceutical companies like Chiesi, Hisamitsu and Organon since its establishment. Kolon Pharmaceutical is also expanding its global presence by exporting its quality products like Flavon(Ginko biloba ext.), Diverine(Gliclazide), Tavisin(Ofloxacin), Clovana(Diclofenac) and Turant(Acetylcysteine) to Vietnam, Pakistan, Yemen and many other Middle Eastern countries. Our continuous efforts led us to fruitful outcomes in significant areas of our business especially new molecule research, joint research, development of API, new formulation and combination new drug.
201 to 500 staff
Hk Inno-N
Since its establishment in 1984, HK inno.N Corp. has tapped into the belief that its business was also helping chart the nation’s future. This belief has served and continues to serve the company well, as it has grown into one of the leading pharmaceutical firms in the nation. Since its establishment in 1984, HK inno.N has gained competitiveness in the businesses of prescription drugs, active pharmaceutical ingredients, health supplements and beauty products. Drawing on the company’s experience and knowhow in developing novel drugs, HK inno.N succeeded in launching ‘K-CAB’, the 30th novel drug to be developed and registered in Korea, to great acclaim. Building on this success, HK inno.N remains committed to growing into a global bio health company built on outstanding products and technologies that bring us closer to a healthier future.
1001 to 5000 staff
Olix Pharmaceuticals, Inc
Accelerating Drug Development using Oligonucleotides Since its discovery, RNA interference (RNAi) technology has been widely recognized as a novel drug development platform that could change the paradigm of therapeutic development. OliX Pharmaceuticals is a clinical stage pharmaceutical company developing therapeutics based on the science of RNAi to address a wide variety of illnesses. The Company has developed core platforms (asymmetric siRNA, cell-penetrating asiRNA) targeting locally administrable diseases, such as hypertrophic scars, hair loss, and age-related macular degeneration (AMD). OliX's third RNAi therapeutic platform, GalNAc-asiRNA, targets multiple liver diseases, including NASH/diabetes and HBV. For the general welfare of human beings, OliX is constantly endeavoring to become a leader in the global biotechnology industry by innovating and expanding its pipeline, even to the undruggable diseases.
51 to 200 staff
Yuyu Pharma
Yuyu Pharma (KRX was founded in 1941 and is a healthcare company located in Korea. The company is publicly traded since 1975. It manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. The key therapeutic markets are CNS, Osteoporosis, Respiratory, and Urology. The R&D center has previously developed two unique improved medicines, Maxmarvil® for patients with osteoporosis and YUCLID® for anti-thrombosis. Currently, Yuyu Pharma has two new drug discovery programs targeting benign prostatic hyperplasia (BPH) and dry eye syndrome. Yuyu Pharma also has various Over-the-counter drugs and dietary supplements, such as YupanC® (vitamin C), Venoplus® (ointment), and Venapollo® (multivitamins)
201 to 500 staff
Sk Biopharmaceuticals
SK Biopharmaceuticals is a part of the global conglomerate SK Group, the second largest company in Korea. We’re responsible for the development of innovative next-generation drugs within SK Group. SK Biopharmaceuticals has been developing many new drug candidates in the area of CNS, led by the clinical development center(SK Life Science) located in United States and the research center in Pangyo Techno-valley, Gyeonggi-do. With the experience and expertise in the CNS area, SK Biopharmaceuticals will continue to thrive as a successful new drug development company and become a trusted partner through its global R&D network. By 2020, SK Biopharmaceuticals envisions to grow into a global Fully Integrated Pharmaceutical Company (FIPCO) with streamlined capabilities from research to marketing. For more information, visit our website at
201 to 500 staff
Kwangdong Pharmaceutical Co., Ltd
1963 ‘ ’, D, 50. ‘ C’ 500, 1. KD. ‘ ’ 2025 1, 1 4, TOM(Top of Mind) Brand ' ’.
1001 to 5000 staff
Nexus Pharma Co., Ltd
Nexus Pharma co, ltd. works to bring the global pharmaceutical community closer together. From small businesses to major pharmaceutical manufacturers, we bring you the highest quality of every pharmaceutical product available in Korea.
11 to 50 staff
Pharmaresearch Co. Ltd
PharmaResearch Co, Ltd. is a biopharmaceutical company leading the regenerative Rx, OTC, Medical Device, Cosmetics and Dietary supplement technology and their market.
201 to 500 staff
Servier Korea
SERVIER KOREA] Servier Korea was established in 1990 as a Korean affiliate of Servier. In order to serve patients’ treatment needs and medical unmet needs, Servier Korea is working on various disease areas including hypertension, diabetes, heart failure, angina, and oncology.
51 to 200 staff
Ckd Bio Corporation
CKD Bio Corporation CKD Bio is devoted to serving the better life through better medicines. with over-70-year experiences in the pharmaceutical industry. CKD Bio manufactures highest quality intermediates and APIs through fully integrated manufacturing process from fermentation to chemical synthesis. CKD Bio is specialized in Contract Manufacturing and Contract Research in the field of fermentation and chemical synthesis. CKD Bio is trying to open the next era by developing the latest and newest generation of pharmaceutical products such as antibiotics, anti-diabetics, anti-fungal and etc.
501 to 1000 staff
Daehwa Pharmaceutical Co., Ltd
DAEHWA was established on Jan. of 1984 and listed in KOSDAQ(Stock market) since 2002. We are running 3 R&D centers and 4 Manufacturing facilities with philosophy of Respecting life / Protection of environment / Advanced Technology that leads pharmaceutical industry. We are tries to contribute to the health and well-being of human race.*R&D Center - Pankyo R&D Center: Mainly research on DDS(Drug Delivery System)/Natural products - Central R&D Center: Mainly research on impovement of products(Formulation and others)- Hyangnam R&D Center: Mainly research on synthesizing of API and others *Manufacturing facility - 1st factory: Mainly manufacturing for oral formulations(Tab./ Cap./ ODF) and external agents as ointment, cream and gel- 2nd factory: Dedicated for manufacturing for TDDS(Transdermal drug delivery system) products as Patch, Plaster, Cataplasma - 3rd factory: Dedicated for anticancer as oral solution (Newly builted for DHP107 - world first oral paclitaxel solution)- Hyangnam Factory: Manufacturing for API and health supplementary and so on. Also, we are running 4subsidiaries company as below- DH Horim: Pharmaceutical wholesaler - Redox-Bio: Synthesizing of HA(Hyaluronic acid)/PDRN/Glutachione and related trading - S-Med: Medical information system contents service - C-Tri: R&D and pharmaceutical manufacturer focusing on Bio-products Among out products, most important product is world first oral paclitaxel solution DHP-107(Project name). This product would be get approval in Korea around 3Q of 2016 for Gastric cancer as first indication. This product adopt the our platform technology DHLASED(DaeHwa Lipid-bAsed Self-Emulsifying Drug delivery system) as first project. For more details and other business cooperation oppotunity, please kindly contact to below email address; crispaul@dhpharm.co.kr (Mr. Paul/Young-Sang Cho - Manager of Overseas Business Dept./ Business Development) Thanks and best regards,
201 to 500 staff
Gccl
Accelerate your global trials with GCCL - All-in-One Clinical Lab Solution (Central Lab + BA Lab + R&D) GCCL, a Lab CRO based in South Korea, specializing in clinical sample analysis services for all phases of trials. With an exclusive lab service available for clinical trials and a logistics system that meets global quality standards, GCCL is building trust with over 200 partners globally by providing a sample analysis and bioanalytical service spanning the entire cycle of clinical trials to meet customer demands.
51 to 200 staff
Organon Korea
& (1577-8582).(*- 9- 6, 5 – )
201 to 500 staff
Inventage Lab
Inventage Lab has the technology to mass-produce micro/nano drug delivery systems using microfluidics technology. Sustained-release injectables using polymeric microspheres have been commercialized, and lipid nano delivery systems such as liposome and LNP are now being manufactured.
51 to 200 staff
Jeil Pharmaceutical Co.,ltd
Jeil Pharmaceutical Co Ltd is a company based out of South Korea.
501 to 1000 staff
Koru Pharma Co., Ltd
Koru Pharma Co, Ltd. is a global biopharmaceutical company specialising in advanced aesthetic and regenerative treatments that inspire confidence and promote overall well-being. We develop and manufacture innovative medical products for corrective and cosmetic use, delivering noticeable improvements and long-lasting outcomes. Our portfolio includes biotechnologies engineered with a strong emphasis on safety, effectiveness, and consistency in clinical practice. Trusted by healthcare professionals in over 100 countries, we collaborate closely with practitioners to provide targeted, reliable solutions that address real-world dermatological needs. By continually investing in research and maintaining meaningful partnerships, we contribute to the evolution of aesthetic medicine — enhancing both practitioner capability and patient experience.
51 to 200 staff
Uppthera, Inc
UPPTHERA, Inc. is a pharmaceutical venture company aiming for new drug development employing 'targeted protein degradation' technology.
51 to 200 staff
Aimed Bio Inc
AIMEDBIO is a spin-off company from Samsung Medical Center with the sole purpose of pursuing after attainable treatment solutions to patients with refractory brain disease, including cancer, in hopes of providing better quality of life. Our primary objective is based on data-driven personalized treatment to address current medical unmet needs in the field of brain disease through international collaborations that we have solidified through years of close partnership. We have an excellent research team with profound achievements, own R&D pipelines with outstanding drug development platform and are building strong global networks with key opinion leaders in the field.
11 to 50 staff
Cho-A Pharmaceutical. Co., Ltd
Since our inaugural export to Vietnam in 1995, Cho A Pharm has consistently grown its global presence by distributing our products across various regions, including the Middle East, Asia, America, and South Africa. We have forged partnerships with over 40 overseas collaborators, including those in the USA, Guatemala, Iran, Vietnam, China, Georgia, and more. With our dedicated manufacturing facility, we offer a diverse range of both off-the-shelf and customized products, ensuring that we can meet your specific business needs efficiently and effectively.
201 to 500 staff
Embocaps
Founded in 1973, the Embocaps® by Suheung brand name is recognized globally as the premium capsule supplier of choice for companies that want the best. Specializing in the production of empty hard capsules for use in pharmaceutical and nutraceutical applications, Embocaps® by Suheung is the industry benchmark for quality.
501 to 1000 staff
